NDC 80777-345 – mRESVIA
Rna-100-ar02 50 ug/.5mL · Suspension · Intramuscular
Product NDC80777-345
Product details
- Brand name
- mRESVIA
- Generic name
- Respiratory Syncytial Virus Vaccine
- Labeler
- Moderna US, INC.
- Dosage form
- Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125796
- Marketed since
- May 31, 2024
- Listing expires
- December 31, 2027
Active ingredients
- Rna-100-ar02 50 ug/.5mL
Package NDC codes (6)
| Package NDC | Description | Since |
|---|---|---|
| 80777-345-61 | 10 SYRINGE in 1 CARTON (80777-345-61) / .5 mL in 1 SYRINGE (80777-345-01) | May 31, 2024 |
| 80777-345-62 | 1 SYRINGE in 1 CARTON (80777-345-62) / .5 mL in 1 SYRINGE (80777-345-01) | May 31, 2024 |
| 80777-345-63 | 2 SYRINGE in 1 CARTON (80777-345-63) / .5 mL in 1 SYRINGE (80777-345-01) | May 31, 2024 |
| 80777-345-89 | 2 SYRINGE in 1 CARTON (80777-345-89) / .5 mL in 1 SYRINGE (80777-345-01) | May 31, 2024 |
| 80777-345-90 | 1 SYRINGE in 1 CARTON (80777-345-90) / .5 mL in 1 SYRINGE (80777-345-01) | May 31, 2024 |
| 80777-345-96 | 10 SYRINGE in 1 CARTON (80777-345-96) / .5 mL in 1 SYRINGE (80777-345-01) | May 31, 2024 |